References

1. Hogberg T, Signorelli M, de Oliveira CF, Fossati R, Lissoni AA, Sorbe B, Andersson H, Grenman S, Lundgren C, Rosenberg P, Boman K, Tholander B, Scambia G, Reed N, Cormio G, Tognon G, Clarke J, Sawicki T, Zola P, Kristensen G. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies. Eur J Cancer. 2010 Sep;46(13):2422-31.

2. Gadducci A, Cosio S, Landoni F, Maggino T, Zola P, Sostegni B, Bellicini A, Fuso L, Cristofani R, Sartori E. Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: An Italian multicenter retrospective study (CTF study). Gynecol Oncol. 2014 Apr 24. pii: S0090-8258(14)00865-8. doi: 10.1016/j.ygyno.2014.04.008. [Epub ahead of print]

3.Miller D, Filiaci V, Fleming G, et al. Randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: a Gynecologic Oncology Group study [abstract]. Gynecol Oncol 2012;125:771.

4. N Colombo, E Preti, F Landoni, S Carinelli, A Colombo, C Marini, C Sessa on behalf of the ESMO Guidelines Working Group. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2013;24(Suppl 6):vi 33-38

5. Oza AM, Elit L, Tsao MS et al. Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group. J Clin Oncol 2011; 29: 32783285.

6. Fader AN, Drake RD, OMalley DM et al. Platinum/taxane based chemotherapy with or without radiation therapy favourably impacts survival outcomes in stage 1 uterine papillary serous carcinoma. Cancer 2009; 115:2119-2127

7. Kelley MG, OMalley DM, Hui P, et al. Improved survival in surgical stage 1 patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. GynecolOncol 2005; 98: 353